Life ScienceCompany
Alcresta Therapeutics Ownership
Who owns Alcresta Therapeutics?
Alcresta Therapeutics is owned by Linden Capital Partners. It was acquired on March 12, 2024.
Is Alcresta Therapeutics PE-backed?
Yes. Alcresta Therapeutics is owned by private equity investor Linden Capital Partners.
Was Alcresta Therapeutics formerly PE-backed?
Yes. Alcresta Therapeutics was formerly owned by 2 private investors.
Alcresta Therapeutics Business Overview
Where is Alcresta Therapeutics headquartered?
Alcresta Therapeutics is headquartered in Newton, Massachusetts.
What sector is Alcresta Therapeutics in?
Alcresta Therapeutics is a life science company.
When was Alcresta Therapeutics founded?
Alcresta Therapeutics was founded in 2011.
Life Science M&A Summary in 2024
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2024. The largest life science acquisition in 2024 was Catalent - which was acquired by Novo Holdings A/S for $16.5B.
Join Mergr to view all 190 acquisitions of life science companies in 2024, including 15 acquisitions by private equity firms, and 175 by strategics.